Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2022 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test

SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye...
November 16, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Partners with Arizona State University to Determine Antibody Levels Against COVID-19

SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
October 02, 2019 18:00 ET | Source: Viome

Viome Named to the 2019 CB Insights Digital Health 150, List of Most Innovative Digital Health Startups

SEATTLE, Oct. 02, 2019 (GLOBE NEWSWIRE) -- CB Insights today named Viome to the inaugural Digital Health 150 rankings, a list of the 150 most promising private digital health companies in the world....
November 17, 2014 16:05 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Enters Into Exclusive Option Agreement to Acquire Engineered Skin Substitute for the Treatment of Severe Burns From Lonza

Engineered Skin substitute (ESS): Phase 1/ Early Phase 2 product candidate that has potential to be a revolutionary new treatment for severe burns ESS granted Orphan Drug designation and,...
October 20, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus CEO Gerald Commissiong Elected to Biotechnology Industry Organization Committees

SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...